Company Overview
REMED BrainStim is an electroceutical specialist dedicated to helping customers live healthier and more beautiful lives.
Starting with the ViBrain(BS-100+) and MUSFIT (MT-100), we are pioneering the world’s first home-use electroceutical market.
The ViBrain(BS-100+) is the world’s first portable TMS device developed for the treatment of intractable brain disorders.
Unlike conventional TMS systems that typically weigh around 80 kg, the ViBrain features a compact, lightweight design of less than 5 kg, enabling effective treatment even in small hospital rooms or at home.
ViBrain has been recognized for its therapeutic effectiveness in treating intractable brain disorders such as depression, dementia, and autism spectrum disorders, and is currently being actively used in clinical settings.
Furthermore, continuous development is underway to enable future integration with wearable devices and ICT (Information and Communication Technology) solutions.
MUSFIT (MT-100) is a medical device that effectively treats muscle pain, benign prostatic hyperplasia (BPH), and urinary incontinence by repeatedly inducing muscle contraction and relaxation through electromagnetic stimulation.
Equipped with a 230 mm-diameter coil and capable of high-frequency stimulation exceeding 50 Hz, it generates a powerful electromagnetic field of 2.5 Tesla, delivering strong and precise stimulation to deeper and broader areas.
Starting with the ViBrain(BS-100+) and MUSFIT (MT-100), we are pioneering the world’s first home-use electroceutical market.
The ViBrain(BS-100+) is the world’s first portable TMS device developed for the treatment of intractable brain disorders.
Unlike conventional TMS systems that typically weigh around 80 kg, the ViBrain features a compact, lightweight design of less than 5 kg, enabling effective treatment even in small hospital rooms or at home.
ViBrain has been recognized for its therapeutic effectiveness in treating intractable brain disorders such as depression, dementia, and autism spectrum disorders, and is currently being actively used in clinical settings.
Furthermore, continuous development is underway to enable future integration with wearable devices and ICT (Information and Communication Technology) solutions.
MUSFIT (MT-100) is a medical device that effectively treats muscle pain, benign prostatic hyperplasia (BPH), and urinary incontinence by repeatedly inducing muscle contraction and relaxation through electromagnetic stimulation.
Equipped with a 230 mm-diameter coil and capable of high-frequency stimulation exceeding 50 Hz, it generates a powerful electromagnetic field of 2.5 Tesla, delivering strong and precise stimulation to deeper and broader areas.
